Stockreport

Sanofi Drug Shows Promise in Asthma After Blood Disorder Success [BNN Bloomberg (Canada)]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The therapy, called rilzabrutinib, helped adults better control their asthma and alleviated symptoms in a mid-stage study, Sanofi said in a statement Wednesday. The res [Read more]